Ashfield Capital Partners’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-19,252
Closed -$3.43M 254
2015
Q3
$3.43M Sell
19,252
-1,269
-6% -$296K 0.22% 84
2015
Q2
$4.56M Sell
20,521
-1,561
-7% -$346K 0.25% 76
2015
Q1
$4.39M Sell
22,082
-3,000
-12% -$532K 0.23% 76
2014
Q4
$3.59M Sell
25,082
-242,372
-91% -$32.6M 0.17% 90
2014
Q3
$35.1M Buy
267,454
+708
+0.3% +$84.4K 1.71% 15
2014
Q2
$33.6M Buy
266,746
+77,824
+41% +$9.93M 1.58% 19
2014
Q1
$24.9M Sell
188,922
-6,019
-3% -$823K 1.2% 35
2013
Q4
$22.9M Sell
194,941
-3,608
-2% -$395K 1.09% 42
2013
Q3
$20.7M Sell
198,549
-7,675
-4% -$748K 1.07% 42
2013
Q2
$17.8M Buy
+206,224
New +$16.3M 0.96% 50

Other funds holding BHC

Ashfield Capital Partners's BHC Position: Q4 2015 in Review

Ashfield Capital Partners sold out of Bausch Health (BHC) in Q4 2015, closing a stake of 19,252 shares — an estimated $3.43M sold.

Ashfield Capital Partners first reported a position in BHC in Q2 2013 and held it in 10 quarters. The position peaked at $35.1M in Q3 2014. 451 funds tracked by Wall St. Rank hold BHC as of Q4 2015.

  • Ashfield Capital Partners reported no remaining Bausch Health position as of Q4 2015 after selling out during the quarter.
  • Ashfield Capital Partners sold 19,252 Bausch Health shares in Q4 2015, an estimated $3.43M.
  • Ashfield Capital Partners first reported a position in Bausch Health in Q2 2013 and held it in 10 quarters.
  • Ashfield Capital Partners's Bausch Health position peaked at $35.1M in Q3 2014.
  • 451 funds tracked by Wall St. Rank held Bausch Health as of Q4 2015.

Based on Ashfield Capital Partners's 13F filing for Q4 2015, filed 10 Feb 2016.